Gilead stock climbs 5% as investors bet company is in a trough, not a plateau
February 07, 2018 at 12:25 PM EST
Wall Street has described 2018 as the company’s ‘trough’ year as other product sales replace falling hepatitis C revenue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.